Vantictumab Biosimilar (FZD Reference Antibody)
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Product Specifications
Target
Vantictumab Biosimilar (Anti-FZD Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP40428_T100-Biotin 100 µL
RBMS1 Antibody - middle region : Biotin (ARP40428_T100-Biotin)
Sign In for Pricing
View Details 
abx227120-01 40 µL
Keratin, Type I Cytoskeletal 20 (KRT20) Antibody
Sign In for Pricing
View Details abx227120-02 100 µL
Keratin, Type I Cytoskeletal 20 (KRT20) Antibody
Sign In for Pricing
View Details